Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt · Delayed Price · Currency is EGP

65.41

-1.05 (-1.58%)

At close: Oct 2, 2025

Revenue by Product

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Antibiotics, Lyophilized Products and Spansule Capsules	5.23B	Log In	Log In	Log In	Log In	Upgrade
Antibiotics, Lyophilized Products and Spansule Capsules Growth	32.27%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Egypt	5.23B	Log In	Log In	Log In	Log In	Upgrade
Egypt Growth	32.27%	Log In	Log In	Log In	Log In	Upgrade